vs
Side-by-side financial comparison of Avidia Bancorp, Inc. (AVBC) and TRINITY BIOTECH PLC (TRIB). Click either name above to swap in a different company.
TRINITY BIOTECH PLC is the larger business by last-quarter revenue ($30.5M vs $26.8M, roughly 1.1× Avidia Bancorp, Inc.). Avidia Bancorp, Inc. runs the higher net margin — 22.9% vs -33.0%, a 55.9% gap on every dollar of revenue. Avidia Bancorp, Inc. produced more free cash flow last quarter ($24.1M vs $-4.1M).
Avidia Bank is an American mutual community bank headquartered in Hudson, Massachusetts. It was founded in 2007 when it was formed by a merger between Hudson Savings Bank and Westborough Bank.
Trinity Biotech PLC develops, manufactures and markets diagnostic test kits and systems for clinical laboratories and point-of-care settings. Its product portfolio covers diabetes management, infectious diseases, cardiac health, autoimmune disorders and coagulation, with core markets across North America, Europe and emerging economies.
AVBC vs TRIB — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2024
| Metric | | |
|---|---|---|
| Revenue | $26.8M | $30.5M |
| Net Profit | $5.3M | $-10.1M |
| Gross Margin | — | 36.8% |
| Operating Margin | 33.3% | -23.2% |
| Net Margin | 22.9% | -33.0% |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.8M | — | ||
| Q3 25 | $28.0M | — | ||
| Q2 25 | $25.9M | — | ||
| Q1 25 | $22.9M | — | ||
| Q2 24 | — | $30.5M | ||
| Q2 22 | — | $37.2M |
| Q4 25 | $5.3M | — | ||
| Q3 25 | $-907.0K | — | ||
| Q2 25 | $3.9M | — | ||
| Q1 25 | $-11.6M | — | ||
| Q2 24 | — | $-10.1M | ||
| Q2 22 | — | $-22.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | 36.8% | ||
| Q2 22 | — | 37.0% |
| Q4 25 | 33.3% | — | ||
| Q3 25 | -7.0% | — | ||
| Q2 25 | 19.4% | — | ||
| Q1 25 | -72.0% | — | ||
| Q2 24 | — | -23.2% | ||
| Q2 22 | — | -5.0% |
| Q4 25 | 22.9% | — | ||
| Q3 25 | -3.2% | — | ||
| Q2 25 | 15.0% | — | ||
| Q1 25 | -50.5% | — | ||
| Q2 24 | — | -33.0% | ||
| Q2 22 | — | -59.0% |
| Q4 25 | — | — | ||
| Q3 25 | $-0.05 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | — | ||
| Q2 22 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $275.0M | $5.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $379.0M | $-29.4M |
| Total Assets | $2.8B | $94.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $275.0M | — | ||
| Q3 25 | $208.3M | — | ||
| Q2 25 | $592.5M | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | $5.3M | ||
| Q2 22 | — | $10.5M |
| Q4 25 | $379.0M | — | ||
| Q3 25 | $372.0M | — | ||
| Q2 25 | $191.4M | — | ||
| Q1 25 | $186.1M | — | ||
| Q2 24 | — | $-29.4M | ||
| Q2 22 | — | $15.8M |
| Q4 25 | $2.8B | — | ||
| Q3 25 | $2.8B | — | ||
| Q2 25 | $3.0B | — | ||
| Q1 25 | $2.7B | — | ||
| Q2 24 | — | $94.4M | ||
| Q2 22 | — | $107.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.4M | $-3.9M |
| Free Cash FlowOCF − Capex | $24.1M | $-4.1M |
| FCF MarginFCF / Revenue | 89.9% | -13.3% |
| Capex IntensityCapex / Revenue | 16.0% | 0.5% |
| Cash ConversionOCF / Net Profit | 5.32× | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.4M | — | ||
| Q3 25 | $24.1M | — | ||
| Q2 25 | $-2.3M | — | ||
| Q1 25 | $-2.2M | — | ||
| Q2 24 | — | $-3.9M | ||
| Q2 22 | — | $-3.4M |
| Q4 25 | $24.1M | — | ||
| Q3 25 | $23.3M | — | ||
| Q2 25 | $-3.3M | — | ||
| Q1 25 | $-3.9M | — | ||
| Q2 24 | — | $-4.1M | ||
| Q2 22 | — | $-3.7M |
| Q4 25 | 89.9% | — | ||
| Q3 25 | 83.2% | — | ||
| Q2 25 | -12.8% | — | ||
| Q1 25 | -16.9% | — | ||
| Q2 24 | — | -13.3% | ||
| Q2 22 | — | -10.0% |
| Q4 25 | 16.0% | — | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 3.7% | — | ||
| Q1 25 | 7.2% | — | ||
| Q2 24 | — | 0.5% | ||
| Q2 22 | — | 0.8% |
| Q4 25 | 5.32× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.60× | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | — | ||
| Q2 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
